Twice-a-year-PReP will only fulfill its potential if Medicaid takes decisive action to ensure it is accessible to the ...

particularly in low- and middle-income countries where it is closely associated with HIV/AIDS. Poor adherence to treatment is common despite various interventions aimed at improving treatment ...

Young people living with HIV play a critical role in the fight against AIDS in communities. They offer support and share ...

In newly released data, lenacapavir, given via a twice-yearly injection, has shown remarkable effectiveness at eliminating ...

AUSTIN (KXAN) — A new affordable and supportive housing complex has opened in north Austin. The Burnet Place Apartments, a 61 ...

It could be a real breakthrough for people at risk for HIV infection: A shot given every 6 months that reduces their risk by a whopping 96%.

methodology by weighted scores for drug potency and the inclusion of treatment history, for example, have increased the precision of the methods. Problems with adherence to the HIV therapy hamper ...

Share on Pinterest Metformin, a common medication used to treat type 2 diabetes, may also help reduce the viral reservoir in people living with HIV who are undergoing antiretroviral therapy.

Canadian researchers say the type 2 diabetes drug metformin could help to reduce the viral reservoir — or even clear it out completely — in people living with human immunodeficiency virus (HIV ...

Standard treatment of babies with HIV typically starts two to three months after birth and continues for decades. This new trial included 54 newborns who were given ART therapy within days of ...

Efavirenz is an important drug for treating HIV infection, but it has negative effects that can significantly impact patients ...